NVCR NovoCure Limited
Healthcare$18.26+1.67%ClosedMarket Cap: $2.11B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$33.50
Target (Median)
$33.50
Target Range
$20.00 - $47.00
Upside from current price: 83.5%
Rating Distribution
1 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-04 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-05-01 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-16 | Wedbush | maintain | Neutral | Neutral |
| 2026-02-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-15 | Wedbush | maintain | Neutral | Neutral |
| 2026-01-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-27 | JP Morgan | maintain | Neutral | Neutral |
| 2025-07-25 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2025-06-27 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.17 | $777.3M | 6 |
| Sun Dec 31 | $-0.61 | $933.9M | 4 |
| Mon Dec 31 | $2.07 | $1.47B | 2 |
| Tue Dec 31 | $4.31 | $1.75B | 2 |